Pharmacotherapy in Neuropathic Pains: Evidence-Based Approach |
Cho, Sang-Hoon
(Department of Oral Medicine, School of Dentistry, Pusan National University)
Ahn, Yong-Woo (Department of Oral Medicine, School of Dentistry, Pusan National University) Ok, Soo-Min (Department of Oral Medicine, School of Dentistry, Pusan National University) Huh, Joon-Young (Department of Oral Medicine, School of Dentistry, Pusan National University) Ko, Myung-Yun (Department of Oral Medicine, School of Dentistry, Pusan National University) Jeong, Sung-Hee (Department of Oral Medicine, School of Dentistry, Pusan National University) |
1 | Martell BA, O'Connor PG, Kerns RD, Becker WC, Morales KH, Kosten TR. et al. Opioid treatment for chronic back pain: prevalence, efficacy and association with addiction. Ann Intern Med 2007;37:116-27 |
2 | Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995;310:452-4. DOI |
3 | Finnerup NB et al. Algorithm for neuropathic pain treatment: An evidence based proposal. Pain 118, 289-305 (2005) DOI ScienceOn |
4 | N. Attal et al. EFENS guidelines on pharmacological treatment of neuropathic pain. European J. Neurology 13:1153-1169 (2006) DOI ScienceOn |
5 | Robert H. Dworkin et al. Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain 132, 237-251 (2007) DOI ScienceOn |
6 | O'Connor AB, Dworkin RH. Treatment of neuropathic pain: an overview of recent guidelines. Am J Med 2009; 122(10, Suppl):S22-S32 DOI ScienceOn |
7 | Dworkin RH, O'Connor AB, Backonja M. et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain; 132(2): 237-251 (2007) DOI |
8 | Khoromi S. Cui L. Nackers L. Max MB. Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain. Pain 2007;130:65-75 |
9 | Raja SN, Haythornthwaite JA, Pappagallo M, Clark MR, Travison TG, Sabeen S, et al. Opioid versus antidepressants in postherpetic neuralgia: a randomized, placebo controlled trial. Neurology 2002;59:1015-21 DOI ScienceOn |
10 | Eisenberg E, McNichol ED, Carr DB. Efficacy and safety of opioid agonists in treatment of neuropathic pain of nonmalignant origin: systemic review and meta-analysis of randomized controlled trials. JAMA 2005;293:3043-52 DOI ScienceOn |
11 | Daniell HW. Hypogonadism in men consuming sustained action oral opioids. J Pain 2002;3:377-84 DOI ScienceOn |
12 | Vallejo R, de Leon-Casasola O, Benyamin R. Opioid therapy and immunosuppression: a review. Am J Ther 2004;11:354-65 DOI ScienceOn |
13 | Chu LF, Clark DJ, Angst MS. Opioid tolerance and hyperalgegia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study. J pain 2006;7:43-8 DOI ScienceOn |
14 | Roza C, Lopez-Garcia JA. Retigabine, the specific KCNQ channel opener, blocks ectopic discharges in axotomized sensory fibres. Pain (2008) (Epub ahead of point). |
15 | Butera JA. Miniperspectives: recent approaches in treatment of neuropathic pain. J. Med. Chem. 50, 2543-2546 (2007) DOI ScienceOn |
16 | Hall GC, Caroll D, Parry D, McQuay H. Epidemiology and treatment of neuropathic pain: The UK primary care perspective. Pain 122, 156-162 (2006) DOI ScienceOn |
17 | Rowbotham MC. Mechanisms of neuropathic pain and their implications for the design of clinical trials. Neurology 65, S66-S73 (2005) DOI ScienceOn |
18 | Kiefer Rt, Rohr P, Ploppa A et al. A pilot open-label study of the efficacy of subanethetic isomeric S+-ketamine in refractory CRPS patients. Pain Med. 9, 44-54 (2008) DOI |
19 | Cvrcek P. Side effects of ketamine in long-term treatment of neuropathic pain. Pain Med. 9, 253-257 (2008) DOI ScienceOn |
20 | AVANIR Pharmaceuticals. Improved patient-centered outcomes with dextromethorphan/quinidine vs placebo in a Phase III, double-blind, randomized, placebo-controlled trial investigating painful diabetic peripheral neuropathy. Presented at: 2nd International Congress On Neuropathic Pain. Berlin, Germany, 7-10 June 2007. |
21 | Finnerup NB, Shindrup SH, Jensen TS. Chronic neuropathic pain: mechanism, drug targets and measurement. Fundam. Clin. Pharmacol. 21, 129-136 (2007) DOI ScienceOn |
22 | Ji RR, Kawaski Y, Zhuang ZY, Wen YR, Decosterd I. Possible role of spinal strocytes in maintaining chronic pain sensitization: review of current evidence with focus on FGF/JNK pathway. Neuron Glia Biol. 2, 259-269 (2006) DOI |
23 | Scholz J, Woolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nature Neurosci. 10, 1361-1368 (2007) DOI ScienceOn |
24 | Cruccu G. Treatment of painful neuropathy. Curr. Opin. NEUrol. 20, 531-535 (2007) |
25 | Finnerup NB, Jensen TS. Mechanism of disease: mechanism-based classification of neuropathic pain a critical analysis. Nature Clin. Pract. Neurol. 2, 107-115 (2006) DOI |